Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
View ORCID ProfileIris Leister, View ORCID ProfileElisabeth Ponocny-Seliger, View ORCID ProfileHerwig Kollaritsch, View ORCID ProfilePeter Dungel, Barbara Holzer, View ORCID ProfileJohannes Grillari, View ORCID ProfileHeinz Redl, View ORCID ProfileIvo Ponocny, Claudia Wilfing, View ORCID ProfileLudwig Aigner, Markus Exner, Michaela Stainer, View ORCID ProfileMatthias Hackl, View ORCID ProfileThomas Hausner, View ORCID ProfileRainer Mittermayr, View ORCID ProfileWolfgang Schaden
doi: https://doi.org/10.1101/2021.02.01.21250898
Iris Leister
1Institute of Molecular Regenerative Medicine, Paracelsus Medical University, Salzburg, Austria
2Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS) and ParaMove, Paracelsus Medical University, Salzburg, Austria
Elisabeth Ponocny-Seliger
3Institute for Quantitative Methods, Sigmund Freud Private University, Vienna, Austria
Herwig Kollaritsch
4Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria
Peter Dungel
5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
6Austrian Cluster for Tissue Regeneration, Vienna, Austria
Barbara Holzer
7Austrian Agency for Health and Food Safety, Mödling, Austria
Johannes Grillari
5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
6Austrian Cluster for Tissue Regeneration, Vienna, Austria
8Institute of Molecular Biotechnology, Department of Biotechnology, BOKU – University of Natural Resources and Life Sciences, Vienna, Austria
Heinz Redl
5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
6Austrian Cluster for Tissue Regeneration, Vienna, Austria
Ivo Ponocny
9Department for Applied Statistics and Economics, Modul University Vienna, Vienna, Austria
Claudia Wilfing
5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
Ludwig Aigner
1Institute of Molecular Regenerative Medicine, Paracelsus Medical University, Salzburg, Austria
2Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS) and ParaMove, Paracelsus Medical University, Salzburg, Austria
Markus Exner
10Labors.at GmbH, Vienna, Austria
Michaela Stainer
5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
6Austrian Cluster for Tissue Regeneration, Vienna, Austria
Matthias Hackl
6Austrian Cluster for Tissue Regeneration, Vienna, Austria
11TAmiRNA GmbH, Vienna, Austria
Thomas Hausner
5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
6Austrian Cluster for Tissue Regeneration, Vienna, Austria
12AUVA Trauma Center Vienna, Vienna, Austria
Rainer Mittermayr
5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
6Austrian Cluster for Tissue Regeneration, Vienna, Austria
12AUVA Trauma Center Vienna, Vienna, Austria
Wolfgang Schaden
5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
6Austrian Cluster for Tissue Regeneration, Vienna, Austria
13AUVA Headquarter, Vienna, Austria
Data Availability
Data can be made available upon reasonable request to the corresponding author.
Posted February 03, 2021.
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
Iris Leister, Elisabeth Ponocny-Seliger, Herwig Kollaritsch, Peter Dungel, Barbara Holzer, Johannes Grillari, Heinz Redl, Ivo Ponocny, Claudia Wilfing, Ludwig Aigner, Markus Exner, Michaela Stainer, Matthias Hackl, Thomas Hausner, Rainer Mittermayr, Wolfgang Schaden
medRxiv 2021.02.01.21250898; doi: https://doi.org/10.1101/2021.02.01.21250898
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
Iris Leister, Elisabeth Ponocny-Seliger, Herwig Kollaritsch, Peter Dungel, Barbara Holzer, Johannes Grillari, Heinz Redl, Ivo Ponocny, Claudia Wilfing, Ludwig Aigner, Markus Exner, Michaela Stainer, Matthias Hackl, Thomas Hausner, Rainer Mittermayr, Wolfgang Schaden
medRxiv 2021.02.01.21250898; doi: https://doi.org/10.1101/2021.02.01.21250898
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4285)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2767)
- Health Policy (1025)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4063)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6667)
- Radiology and Imaging (1456)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)